Ace inhibitor therapy for heart failure in patients with impaired renal function: A review of the literature

Heart Failure Reviews

Volumn 18, Issue 2, 2013, Pages 135-140

  Valika, Ali A ^a   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Ace inhibitor; Acute kidney disease; Angiotensin receptor blocker; Cardiorenal; Chronic kidney disease; Heart failure; Worsening renal function

Indexed keywords

BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LOSARTAN; PLACEBO;

ACUTE HEART FAILURE; ARTICLE; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; PATHOPHYSIOLOGY; SODIUM EXCRETION; SURVIVAL RATE;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE; HUMANS; KIDNEY; RENAL INSUFFICIENCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84879464456     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9295-6     Document Type: Article

References (26)

1. Hall JE, et al. (1977) Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233(5):F366-F372
2. Ainscough JF, et al. (2009) Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res 81(3):592-600
3. Ruggenenti P, Remuzzi G (2011) Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney. Eur Heart J 32(20):2476-2478
4. Enseleit F, Hurlimann D, Luscher TF (2001) Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 37(Suppl 1):S21-S30
5. Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160(5):685-693 (Pubitemid 30140419)
6. Ljungman S, Kjekshus J, Swedberg K (1992) Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). Am J Cardiol 70(4):479-487
7. Swedberg K, Kjekshus J, Snapinn S (1999) Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 20(2):136-139 (Pubitemid 29048084)
8. Blair JE, et al. (2011) Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J 32(20):2563-2572
9. Oster JR, Materson BJ (1992) Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch Intern Med 152(4):704-710
10. Packer M, et al. (1987) Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 106(3):346-354 (Pubitemid 17029483)
11. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349(9069):1857-1863 (Pubitemid 27270118)
12. Ruggenenti P, Perna A, Remuzzi G (2001) ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy. J Am Soc Nephrol 12(12):2832-2837 (Pubitemid 33115432)
13. Hou FF, et al. (2006) Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354(2):131-140 (Pubitemid 43076710)
14. Klahr S, et al. (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of diet in renal disease study group. N Engl J Med 330(13):877-884 (Pubitemid 24094966)
15. Jafar TH, et al. (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139(4):244-252
16. Carr AA, et al. (2005) Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol 96(11):1530-1536 (Pubitemid 41690173)
17. Berl T, et al. (2003) Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138(7):542-549
18. Ahluwalia SC, et al. (2011) Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med 26(10):1145-1151
19. Badve SV, et al. (2011) Effects of Beta-adrenergic antagonists in patients with chronic kidney disease a systematic review and meta-analysis. J Am Coll Cardiol 58(11):1152-1161
20. Chang TI, Chertow GM (2011) Chronic kidney disease and cardiovascular therapeutics time to close the evidence gaps. J Am Coll Cardiol 58(11):1162-1164
21. Desai AS, et al. (2007) Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM program. J Am Coll Cardiol 50(20):1959-1966 (Pubitemid 350046342)
22. Anand IS, et al. (2009) Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin- converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation 120(16):1577-1584
23. McAlister FA, et al. (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004-1009 (Pubitemid 38282853)
24. Zannad F, et al. (2006) Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 70(7):1318-1324 (Pubitemid 44435184)
25. Cice G, et al. (2010) Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J Am Coll Cardiol 56(21):1701-1708
26. Motwani JG, et al. (1992) Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Circulation 86(2):439-445